Technical Analysis for HRTX - Heron Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 25.42 -0.55% -0.14
HRTX closed down 0.55 percent on Friday, December 13, 2019, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
See historical HRTX trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Doji - Bullish? Reversal 0.00%
Down 3 Days in a Row Weakness 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -0.55%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.55%
Outside Day Range Expansion -0.55%
1,2,3 Pullback Bullish Bullish Swing Setup -0.66%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.66%
Wide Bands Range Expansion -0.66%
Older signals for HRTX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. The company's drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that should be injected once or twice per day to products that need to be injected once every one or two weeks. Its lead product candidate, Sustol, is developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting for patients undergoing emetogenic chemotherapy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.
Medicine Health Pharmaceutical Clinical Medicine Oncology Chemotherapy Cancer Treatments Occupational Safety And Health Antineoplastic Drugs Drug Delivery Injectable Pharmaceuticals

Is HRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.7
52 Week Low 15.68
Average Volume 1,017,485
200-Day Moving Average 20.38
50-Day Moving Average 21.77
20-Day Moving Average 25.00
10-Day Moving Average 25.84
Average True Range 0.86
ADX 41.4
+DI 23.41
-DI 12.22
Chandelier Exit (Long, 3 ATRs ) 24.22
Chandelier Exit (Short, 3 ATRs ) 22.62
Upper Bollinger Band 27.62
Lower Bollinger Band 22.37
Percent B (%b) 0.58
BandWidth 20.97
MACD Line 1.13
MACD Signal Line 1.32
MACD Histogram -0.1854
Fundamentals Value
Market Cap 1.38 Billion
Num Shares 54.1 Million
EPS -4.15
Price-to-Earnings (P/E) Ratio -6.13
Price-to-Sales 59.70
Price-to-Book 11.60
PEG Ratio -0.17
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.47
Resistance 3 (R3) 26.52 26.21 26.30
Resistance 2 (R2) 26.21 25.95 26.19 26.24
Resistance 1 (R1) 25.82 25.78 26.02 25.77 26.18
Pivot Point 25.51 25.51 25.61 25.49 25.51
Support 1 (S1) 25.12 25.25 25.32 25.07 24.66
Support 2 (S2) 24.81 25.08 24.79 24.60
Support 3 (S3) 24.42 24.81 24.55
Support 4 (S4) 24.37